glp 1 drugs and vision loss GLP-1 linked to rare loss: JAMA study | Pharmavoice.in posted on the topic Vision loss risks in patients

A 2025 study of 228,000 individuals with obesity, Type 2 diabetes, or alcohol use disorder, semaglutide and liraglutide use was associated with a 36% and 28% lower risk, respectively, of alcohol-related hospitalizations (such as intoxication and withdrawal symptoms) compared to patients who weren't prescribed GLP-1 medications (Lhteenvuo et al., 2025)

While Samols was away another group of researchers at the Royal Free Hospital made a significant breakthrough in unravelling the role of the pancreas islet cells in insulin secretion

Gier et al (38) reported PanIN lesions located primarily in pancreatic duct glands of normal rats treated with exendin-4

From curiosity-seekers trying to understand these new options to individuals actively seeking weight-loss solutions, a wide swath of internet users have been part of this surge

These events are dose-dependent and most pronounced during dose escalation